SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VGNX -- Variagenics, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who started this subject10/18/2001 3:24:59 PM
From: scaram(o)uche  Read Replies (1) of 269
 
from the "it could be worse" file..... I'd be really ticked, were I a GNSC shareholder........

Thursday October 18, 3:09 pm Eastern Time

Genaissance Pharma files $35 mln shelf offering

WASHINGTON, Oct 18 (Reuters) - Genaissance Pharmaceuticals Inc.
(NasdaqNM:GNSC - news) filed on Thursday with the Securities and Exchange Commission
to periodically sell up to $35 million in common and preferred stock, debt securities and
warrants. (snip)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext